<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Process" Owner="NLM">        <PMID Version="1">30149216</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>12</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1873-4235</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>120</Volume>                    <PubDate>                        <Year>2018</Year>                        <Month>Nov</Month>                        <Day>30</Day>                    </PubDate>                </JournalIssue>                <Title>Biosensors &amp; bioelectronics</Title>                <ISOAbbreviation>Biosens Bioelectron</ISOAbbreviation>            </Journal>            <ArticleTitle>In situ plasmonic generation in functional ionic-gold-nanogel scaffold for rapid quantitative bio-sensing.</ArticleTitle>            <Pagination>                <MedlinePgn>77-84</MedlinePgn>            </Pagination>            <ELocationID EIdType="pii" ValidYN="Y">S0956-5663(18)30615-8</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bios.2018.08.019</ELocationID>            <Abstract>                <AbstractText>Conventional analytical techniques, which have been developed for high sensitivity and selectivity for the detection and quantification of relevant biomarkers, may not be as suitable for medical diagnosis in resource scarce environments as compared to point-of-care devices (POC). We have developed a new reactive sensing material which contains ionic gold entrapped within an agarose gel scaffold for POC quantification of ascorbic acid (AA) in tear fluid. Pathologically elevated concentration of AA in human tear fluid can serve as a biomarker for full-thickness injuries to the ocular surface, which are a medical emergency. This reactive sensing material will undergo colorimetric changes, quantitatively dependent on endogenous bio-reductants that are applied, as the entrapped ionic gold is reduced to form plasmonic nanoparticles. The capacity for this reactive material to function as a plasmonically driven biosensor, called 'OjoGel' (ojo-eye), was demonstrated with the endogenous reducing agent, AA. Through applications of AA of varied concentrations to the OjoGel, we demonstrated a quantitative colorimetric relationship between red (R) hexadecimal values and concentrations of AA in said treatments. This colorimetric relationship is directly resultant of plasmonic gold nanoparticle formation within the OjoGel scaffold. Using a commercially available mobile phone-based Pixel Picker<sup>®</sup> application, the OjoGel plasmonic sensing platform opens a new avenue for easy-to-use, rapid, and quantitative biosensing with low cost and accurate results.</AbstractText>                <CopyrightInformation>Copyright © 2018 Elsevier B.V. All rights reserved.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Misra</LastName>                    <ForeName>Santosh K</ForeName>                    <Initials>SK</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Bioengineering, Materials Science and Engineering, Beckman Institute, University of Illinois Urbana-Champaign, Urbana, IL, USA; Mills Breast Cancer Institute, Carle Foundation Hospital, Urbana, IL, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Dighe</LastName>                    <ForeName>Ketan</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Bioengineering, Materials Science and Engineering, Beckman Institute, University of Illinois Urbana-Champaign, Urbana, IL, USA; Mills Breast Cancer Institute, Carle Foundation Hospital, Urbana, IL, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Schwartz-Duval</LastName>                    <ForeName>Aaron S</ForeName>                    <Initials>AS</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Bioengineering, Materials Science and Engineering, Beckman Institute, University of Illinois Urbana-Champaign, Urbana, IL, USA; Mills Breast Cancer Institute, Carle Foundation Hospital, Urbana, IL, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Shang</LastName>                    <ForeName>Zaixi</ForeName>                    <Initials>Z</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Bioengineering, Materials Science and Engineering, Beckman Institute, University of Illinois Urbana-Champaign, Urbana, IL, USA; Mills Breast Cancer Institute, Carle Foundation Hospital, Urbana, IL, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Labriola</LastName>                    <ForeName>Leanne T</ForeName>                    <Initials>LT</Initials>                    <AffiliationInfo>                        <Affiliation>Ophthalmology Department, Carle Foundation Hospital, Urbana, IL, USA; Surgery Department, University of Illinois College of Medicine, Urbana, IL, USA; Interdisciplinary Health Science Initiative, University of Illinois, Urbana, IL, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Pan</LastName>                    <ForeName>Dipanjan</ForeName>                    <Initials>D</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Bioengineering, Materials Science and Engineering, Beckman Institute, University of Illinois Urbana-Champaign, Urbana, IL, USA; Mills Breast Cancer Institute, Carle Foundation Hospital, Urbana, IL, USA; Carle Illinois College of Medicine, Urbana, IL, USA; Interdisciplinary Health Science Initiative, University of Illinois, Urbana, IL, USA. Electronic address: dipanjan@illinois.edu.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>11</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Biosens Bioelectron</MedlineTA>            <NlmUniqueID>9001289</NlmUniqueID>            <ISSNLinking>0956-5663</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Ascorbic acid</Keyword>            <Keyword MajorTopicYN="N">Biomarker</Keyword>            <Keyword MajorTopicYN="N">Biosensors</Keyword>            <Keyword MajorTopicYN="N">Gold nanoparticles</Keyword>            <Keyword MajorTopicYN="N">Plasmonic nanogel</Keyword>            <Keyword MajorTopicYN="N">Point-of-care (POC)</Keyword>            <Keyword MajorTopicYN="N">Tear film</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>05</Month>                <Day>29</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>07</Month>                <Day>21</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>08</Month>                <Day>10</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>28</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>28</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>28</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30149216</ArticleId>            <ArticleId IdType="pii">S0956-5663(18)30615-8</ArticleId>            <ArticleId IdType="doi">10.1016/j.bios.2018.08.019</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>